IBO — Universal Ibogaine Balance Sheet
0.000.00%
Last trade - 00:00- CA$3.09m
- CA$5.39m
- CA$1.03m
- 11
- 46
- 27
- 18
Annual balance sheet for Universal Ibogaine, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2022 July 31st | 2023 July 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 0.726 | 0.313 |
| Net Total Receivables | 0.231 | 0.076 |
| Prepaid Expenses | ||
| Total Current Assets | 1.02 | 0.443 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 5.3 | 3.66 |
| Other Long Term Assets | ||
| Total Assets | 6.32 | 5.5 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 2.19 | 2.79 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 2.37 | 3.75 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 3.94 | 1.75 |
| Total Liabilities & Shareholders' Equity | 6.32 | 5.5 |
| Total Common Shares Outstanding |